Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HRS-2261 / Jiangsu Hengrui Pharma
NCT05733533: A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough	Enrolling by invitation	2	304	RoW	HRS-2261 oral tablet, Matching placebo to HRS-2261	Guangdong Hengrui Pharmaceutical Co., Ltd	Refractory Chronic Cough	03/24	03/24
NCT05274516: A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration	Completed	1	92	RoW	HRS-2261 tablet、placebo	Guangdong Hengrui Pharmaceutical Co., Ltd	Chronic Cough	10/22	10/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HRS-2261 / Jiangsu Hengrui Pharma
NCT05733533: A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough	Enrolling by invitation	2	304	RoW	HRS-2261 oral tablet, Matching placebo to HRS-2261	Guangdong Hengrui Pharmaceutical Co., Ltd	Refractory Chronic Cough	03/24	03/24
NCT05274516: A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration	Completed	1	92	RoW	HRS-2261 tablet、placebo	Guangdong Hengrui Pharmaceutical Co., Ltd	Chronic Cough	10/22	10/22